Request Demo
Last update 15 May 2026
AlphaNa Bioscience Co., Ltd.
Last update 15 May 2026
Overview
Tags
Neoplasms
Infectious Diseases
Skin and Musculoskeletal Diseases
mRNA
in vivo CAR-T therapy
mRNA vaccine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT07408336
Clinical Study of AFN50 Injection in the Autoimmune Diseases
CTR20253368
随机、盲法、对照设计评价带状疱疹病毒（VZV）mRNA疫苗（AFN1213）在40岁及以上人群中接种的安全性、耐受性，初步探索免疫原性的Ⅰ期临床试验
[Translation] A randomized, blinded, controlled Phase I clinical trial to evaluate the safety and tolerability of the herpes zoster virus (VZV) mRNA vaccine (AFN1213) in people aged 40 years and older, and to preliminarily explore its immunogenicity.
CTR20252307
随机、盲法、安慰剂对照设计评价50岁及以上人群接种1剂不同剂量的呼吸道合胞病毒mRNA疫苗的免疫原性和安全性的Ⅱ期临床试验
[Translation] A randomized, blinded, placebo-controlled phase II clinical trial to evaluate the immunogenicity and safety of one dose of different doses of respiratory syncytial virus mRNA vaccine in people aged 50 years and above
100 Clinical Results associated with AlphaNa Bioscience Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with AlphaNa Bioscience Co., Ltd.
Login to view more data
100 Translational Medicine associated with AlphaNa Bioscience Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 19 May 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
1
4
Phase 1
Phase 2
1
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free